QQ客服 官方微博 反馈留言

	Prophylaxis vs. on-demand treatment with BAY 81-8973, a full-length plasma protein-free recombinant factor VIII product: results from a randomized trial (LEOPOLD II)
	Kavakli, K.; Yang, R.; Rusen, L.; Beckmann, H.; Tseneklidou-Stoeter, D.; Enriquez, M. Maas
	2015
卷号	13期号:3页码:360-369
关键词	factor VIII hemophilia A prophylaxis recombinant proteins therapeutic equivalency
ISSN号	1538-7933
DOI	10.1111/jth.12828
URL标识	查看原文
收录类别	SCIE
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/6661814
专题	中国医学科学院 北京协和医学院
推荐引用方式 GB/T 7714	Kavakli, K.,Yang, R.,Rusen, L.,et al. Prophylaxis vs. on-demand treatment with BAY 81-8973, a full-length plasma protein-free recombinant factor VIII product: results from a randomized trial (LEOPOLD II)[J],2015,13(3):360-369.
APA	Kavakli, K.,Yang, R.,Rusen, L.,Beckmann, H.,Tseneklidou-Stoeter, D.,&Enriquez, M. Maas.(2015).Prophylaxis vs. on-demand treatment with BAY 81-8973, a full-length plasma protein-free recombinant factor VIII product: results from a randomized trial (LEOPOLD II).,13(3),360-369.
MLA	Kavakli, K.,et al."Prophylaxis vs. on-demand treatment with BAY 81-8973, a full-length plasma protein-free recombinant factor VIII product: results from a randomized trial (LEOPOLD II)".13.3(2015):360-369.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。